Healthcare

Recent clinical trial data from Ocular Therapeutix has generated significant attention within ophthalmology investment circles. The company's key drug candidate,...

Iqvia Holdings Inc. is accelerating the digital transformation of the life sciences sector through a strategic technology alliance. The company...

Grail finds itself at a pivotal juncture, marked by a significant change in executive leadership and a notable shift in...

As the spring season progresses, market attention is turning to Diversified Healthcare Trust's operational performance following its latest annual report...

The coming months represent a period of significant strategic execution for U.S. healthcare giant Centene. Management is sending a clear...

The flavors and fragrances group Symrise AG is implementing a significant reorganization of its cosmetics activities. In a strategic response...

A key medical authority has broadened its treatment recommendations for bladder cancer, providing a notable boost for ImmunityBio's commercial prospects....

A significant strategic pivot by telehealth provider Hims & Hers has prompted a swift reassessment from Wall Street. The company...

Facing significant challenges in its core Medicare Advantage business and increased antitrust scrutiny, UnitedHealth Group is strategically pivoting to bolster...

New preclinical findings for Anavex Life Sciences' lead drug candidate, Blarcamesine, were unveiled at the AD/PD 2026 conference in Copenhagen....